SCHEDULE 13G: Hudson View Group Discloses 5.55% Stake in Mural Oncology plc
Beneficial Ownership Report
Hudson View Holdings LLC, Hudson View Capital LLC, Stuart Feldman, and Matthew Barkoff have jointly disclosed a beneficial ownership of 5.55% in Mural Oncology plc's Ordinary Shares.
Summary
- Hudson View Holdings LLC, Hudson View Capital LLC, Stuart Feldman, and Matthew Barkoff (collectively, the "Reporting Persons") have filed a Schedule 13G, indicating their beneficial ownership in Mural Oncology plc.
- As of April 16, 2025, the Reporting Persons collectively beneficially own 957,000 Ordinary Shares of Mural Oncology plc.
- This aggregate ownership represents 5.55% of the outstanding Ordinary Shares of Mural Oncology plc.
- Hudson View Holdings LLC, Hudson View Capital LLC, and Stuart Feldman each hold sole voting and dispositive power over 765,600 shares.
- Matthew Barkoff holds sole voting and dispositive power over 191,400 shares.
- The Reporting Persons have certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 240.14a-11.
- The principal executive offices of Mural Oncology plc are located in Dublin, Ireland.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing indicates a significant passive investment by a group of entities and individuals in Mural Oncology plc, a company in the oncology sector. Such disclosures are common for institutional investors or investment groups accumulating stakes in publicly traded companies.
Stakeholder Impact
- Shareholders: The disclosure of a new significant beneficial owner (5.55%) could be viewed as a vote of confidence or a signal of potential future engagement by the investment group. It increases transparency regarding the company's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 04/16/2025 | Date of the event which required the filing of this statement (beneficial ownership threshold crossed). |
| 05/09/2025 | Date of the Joint Filing Agreement among the Reporting Persons. |
| 05/09/2025 | Date of the Power of Attorney granted by Stuart Feldman to Joseph Brucchieri and Jeffrey Goldberg. |
| 05/12/2025 | Date the Schedule 13G filing was signed by the Reporting Persons. |
Keywords
Mural Oncology plc, Hudson View Holdings LLC, Hudson View Capital LLC, Stuart Feldman, Matthew Barkoff, Schedule 13G, Beneficial Ownership, Ordinary Shares, SEC Filing, Investment Group
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.